Coverage
-
April 01, 2013
A Delaware federal judge on Saturday handed a win to Cephalon Inc. in its patent infringement suit aiming to block the sale of generic versions of the narcolepsy drug Nuvigil, rejecting generic-drug makers' claims that Cephalon's patent on the drug was invalid.
2 other articles on this case.
View all »